Articles related to SCHIZOPHRENIA

This recent Supreme Court ruling sheds light on the critical intersection of mental health and legal standards, offering an essential perspective for healthcare professionals involved in forensic or psychiatric fields.

The Johns Hopkins Clozapine Consultation Clinic is addressing the critical underutilization of clozapine in treatment-resistant schizophrenia, providing essential support and education for healthcare providers in navigating its benefits and risks.

LYN-005 represents a breakthrough in schizophrenia management, showing promise in maintaining therapeutic levels and symptom control with just once-weekly dosing.

Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.

The JEWEL study has demonstrated that lurasidone treatment in patients with schizophrenia results in significant improvements in social functioning, with notable progress observed from the early stages of treatment and sustained benefits over a 12-week extension period.

In an exciting development for schizophrenia research, Dr. Pan Li’s team utilizes CRISPR/Cas9 to explore neuron cell development, focusing on rare gene variants.